Status:
UNKNOWN
Corticosteroid vs Platelet-Rich Plasma Intra-articular Injections in the Treatment of Knee Osteoarthritis.
Lead Sponsor:
The University of The West Indies
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
50+ years
Phase:
EARLY_PHASE1
Brief Summary
This study will explore the effectiveness of intra-articular knee injections in patients with osteoarthritis by comparing Corticosteroid (triamcinolone) vs Platelet Rich Plasma (PRP). This study is a...
Detailed Description
This study will explore the effectiveness of intra-articular knee injections in patients with osteoarthritis by comparing Corticosteroid (triamcinolone) vs Platelet Rich Plasma (PRP). This study is a...
Eligibility Criteria
Inclusion
- Kellgren and Lawrence grades 2-3 Age 50 years and older
Exclusion
- Patients with secondary OA:
- History of Fractures around the knee joint i. patella ii. tibia plateau iii. intra articular distal femur
- Bleeding diathesis
- History of septic arthritis
- Patients on oral steroid medications
- Patients who received intraarticular steroid injection \< 6 months before enrollment
- Sickle Cell Disease
- Rheumatoid arthritis
- Patients with a diagnosis of knee OA with little or no pain
- Patient with a diagnosis of knee OA being successfully managed with oral medications and physiotherapy
- Knee pain not attributed to a diagnosis of OA
- All patients who refuse to participate
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2025
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06032039
Start Date
October 1 2023
End Date
April 30 2025
Last Update
May 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of the West Indies
Kingston, Jamaica